Savara (SVRA) Long-Term Investments (2012 - 2016)
Savara (SVRA) reported Long-Term Investments of $2.7 million for Q4 2016, down 84.72% year-over-year from $17.9 million in Q1 2016, and down 57.38% quarter-over-quarter from $6.4 million in Q3 2016.
Savara (SVRA) Long-Term Investments (2012 - 2016) Analysis & Trends
Savara (SVRA) has 5 years of Long-Term Investments data on file, last reported at $2.7 million in Q4 2016.
- Long-Term Investments for Q4 2016 came in at $2.7 million, down 84.72% year-over-year; the trailing twelve-month figure through Dec 2016 was $2.7 million (down 84.72% YoY), and the FY2016 annual result was $2.7 million, down 84.72% from the prior year.
- Long-Term Investments fell to $2.7 million in Q4 2016 per SVRA's latest filing, from $6.4 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $22.2 million in Q2 2015 and troughed at $2.7 million in Q4 2016.
- A 5-year average of $16.2 million and a median of $17.9 million in 2015 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2013 and 2016: Long-Term Investments soared 33.55% in 2013, then tumbled 84.72% in 2016.
- A 5-year view of Long-Term Investments shows it stood at $14.0 million in 2012, then soared by 33.55% to $18.7 million in 2013, then rose by 14.8% to $21.5 million in 2014, then fell by 16.54% to $17.9 million in 2015, then plunged by 84.72% to $2.7 million in 2016.
- Business Quant data shows SVRA's Long-Term Investments at $2.7 million in Q4 2016, $6.4 million in Q3 2016, and $10.6 million in Q2 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.74 Mn |
| Sep 30, 2016 | 6.43 Mn |
| Jun 30, 2016 | 10.58 Mn |
| Mar 31, 2016 | 13.57 Mn |
| Dec 31, 2015 | 17.93 Mn |
| Sep 30, 2015 | 17.71 Mn |
| Jun 30, 2015 | 22.17 Mn |
| Mar 31, 2015 | 21.95 Mn |
| Dec 31, 2014 | 21.48 Mn |
| Sep 30, 2014 | 17.09 Mn |
| Jun 30, 2014 | 20.07 Mn |
| Mar 31, 2014 | 19.77 Mn |
| Dec 31, 2013 | 18.71 Mn |
| Sep 30, 2013 | 19.13 Mn |
| Dec 31, 2012 | 14.01 Mn |